About the Authors
- József Prechl
-
* E-mail: jprechl@diagnosticum.com
Affiliations Diagnosticum Zrt, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary
- Krisztián Papp
-
Affiliation MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary
- Zoltán Hérincs
-
Affiliation Diagnosticum Zrt, Budapest, Hungary
- Hajna Péterfy
-
Affiliation Diagnosticum Zrt, Budapest, Hungary
- Veronika Lóránd
-
Affiliation Department of Rheumatology and Immunology, Clinic Center, University of Pécs, Pécs, Hungary
- Zoltán Szittner
-
Affiliation MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary
- Andone Estonba
-
Affiliation Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Bilbao, Spain
- Paolo Rovero
-
Affiliation Department of NeuroFarBa, University of Florence, Florence, Italy
- Ilaria Paolini
-
Affiliation Toscana Biomarkers, Siena, Italy
- Jokin del Amo
-
Affiliation Progenika Biopharma S.A., a Grifols Company, Derio, Bizkaia, Spain
- Maria Uribarri
-
Affiliation Progenika Biopharma S.A., a Grifols Company, Derio, Bizkaia, Spain
- Maria Claudia Alcaro
-
Affiliation Toscana Biomarkers, Siena, Italy
- Otsanda Ruiz-Larrañaga
-
Affiliation Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Bilbao, Spain
- Paola Migliorini
-
Affiliation Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- László Czirják
-
Affiliation Department of Rheumatology and Immunology, Clinic Center, University of Pécs, Pécs, Hungary
Competing Interests
József Prechl, Zoltán Hérincs and Hajna Péterfy are employed by Diagnosticum Zrt, Ilaria Paolini and Maria Claudia Alcaro by Toscana Biomarkers and Jokin Del Amo and Maria Uribarri by Progenika. Paolo Rovero and Paola Migliorini are shareholders of Toscana Biomarkers. József Prechl and Krisztián Papp are inventors of a patent for microarray-based monitoring of antigen specific complement activation (EP2047269B1), which is owned by Eötvös Loránd Unniversity and Hungarian Academy of Sciences and is licensed by Diagnosticum zrt. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: PR IP MCA LC. Performed the experiments: KP ZH HP ZS AE PM. Analyzed the data: JP KP VL JDA MU. Contributed reagents/materials/analysis tools: PR. Wrote the paper: JP ORL KP LC. Recruited patients: PM VL LC.